Relationship Between Nuchal Fold Thickness and Fetal Heart Disease in Pregnant Women Referred to a Pediatric Hospital in Bandar Abbas During ۲۰۱۸-۲۰۱۹

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 191

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IEJM-8-2_009

تاریخ نمایه سازی: 23 دی 1399

Abstract:

Background: Congenital heart disease (CHD) is of the most common congenital anomalies. Most of the major cardiac defects can be diagnosed by fetal echocardiography at ۲۰ weeks of gestation. Evaluation of nuchal thickness can be the first stage of screening in the diagnosis of CHD. Therefore, this study aimed to investigate the relationship between nuchal translucency (NT) and CHD in pregnant women. Materials and Methods: The current study is an analytical-descriptive study conducted on fetuses of ۴۴ pregnant women. Abdominal sonography of the participants at ۱۰-۱۴ weeks of gestation was performed, and they referred to a pediatric hospital in Bandar Abbas in order to undergo fetal echocardiography at ۱۷-۱۸ weeks of gestation. Results: The mean age of the participants was ۲۸ ± ۶ years. Out of ۴۴ pregnant women, fetal heart disease was diagnosed in ۴ pregnancies (۹%), one of whom was reported as ۲.۵≤NT<۳.۵ and three cases were reported as ۳.۵≤NT. Out of ۴۰ women with no fetal heart disease, two cases had NT≥۳.۵, ۱۲ cases had ۲.۵≤NT<۳.۵ and ۲۶ cases had NT>۲.۵. Conclusion: The results of this study showed that ۶.۸% of the cases of CHD had an increase in the thickness of NT (NT≥۳.۵) at ۱۰-۱۴ weeks of gestation. The sensitivity of this screening method was ۷۵% at ۱۸-۲۰ weeks of gestation which is low for general population. Therefore, NT cannot be regarded as the only or main screening tool for CHD.

Authors

Sepideh Fuladi

Student Research Committee, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Maziar Rastegar

Department of Cardiovascular Diseases, Pediatrics Hospital, Hormozgan University of Medical Sciences, Bandar Abbas, Iran